Nursing staff administering antineoplastic drugs who require biennial assessment to demonstrate ongoing clinical competency. All new to Waitemata DHB nursing staff who have previously completed eviQ in another health care setting.
The Antineoplastic Drug Administration Course (ADAC) supports health professionals develop the necessary knowledge and clinical skills to administer antineoplastic drugs via different routes and handle related waste safely. ADAC uses eviQ content to develop education courses that are based upon the best and most comprehensive evidence available at the time of development. ADAC was developed by the Cancer Institute NSW and follows a strict governance process.
- Editing Trainer: Rebecca Powell
- Editing Trainer: Carolyn Turnhout
This course is appropriate for both clinical and non clinical staff who need to develop an understanding of the principles of safe handling and management of cytotoxic wastes but will not be administering antineoplastic/cytotoxic drugs. Nurses who will be administering antineoplastic medications in any setting should not do this course. Contact and Lead Facilitatr: Carolyn Turnhout |
|
- Editing Trainer: Manjula Deo
- Editing Trainer: Louise Guy
- Editing Trainer: Rebecca Powell
- Editing Trainer: Karen Purdie
- Editing Trainer: Carolyn Turnhout
|
The Antineoplastic Drug Administration Course (ADAC) is for nurses who will be required to administer antineoplastic medications in a clinical setting with patients who have a cancer diagnosis. This course supports health professionals develop the necessary knowledge and clinical skills to administer antineoplastic drugs via different routes and handle related waste safely. ADAC uses eviQ content to develop education courses that are based upon the best and most comprehensive evidence available at the time of development. ADAC was developed by the Cancer Institute NSW and follows a strict governance process. The course includes high quality interactive scenario based eLearning guides, eQuizzes, supervised clinical practice, competency assessments and a clinical skills workshop to consolidate theory to practice. It is recommended that clinical participants meet the following prerequisites:
Contact and Lead Facilitatr: Carolyn Turnhout |
|
- Editing Trainer: Manjula Deo
- Editing Trainer: Rebecca Powell
- Editing Trainer: Priscilla Tang
- Editing Trainer: Carolyn Turnhout
The Antineoplastic Drug Administration Course (ADAC) is for nurses who will be required to administer antineoplastic medications in a clinical setting with patients who do not have a cancer diagnosis. This course supports health professionals develop the necessary knowledge and clinical skills to administer antineoplastic drugs via different routes and handle related waste safely. ADAC uses eviQ content to develop education courses that are based upon the best and most comprehensive evidence available at the time of development. ADAC was developed by the Cancer Institute NSW and follows a strict governance process. The course includes high quality interactive scenario based eLearning guides, eQuizzes, supervised clinical practice, and competency assessments. It is recommended that clinical participants meet the following prerequisites:
|
|
- Editing Trainer: Louise Guy
- Editing Trainer: Rebecca Powell
- Editing Trainer: Karen Purdie
- Editing Trainer: Carolyn Turnhout
Intended audience: Children's Community Nurses ONLY
Duration: 10-15 minutes
About this course: This is an annual reassessment module for Antineoplastic Drug Administration for Children's Community Nurses only. If you are doing the main eviQ ADAC courses, please see the other courses in this category.
- Editing Trainer: Carol Banks
- Editing Trainer: Louise Guy
- Editing Trainer: Karen Purdie
